Related Experiment Video
Updated: Jul 16, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
HIV viral diversity and escape from cellular immunity
Nicole Frahm1, Christian Brander
1Partners AIDS Research Center, 5th Floor MGH East, #5239, 149 13th Street, Charlestown, MA 02129-2000, USA.
Developing an effective HIV vaccine is challenging due to the virus's rapid adaptation and immune evasion. Understanding immune responses and viral kinetics is key to designing broadly applicable vaccines against human immunodeficiency virus (HIV).
Area of Science:
- Immunology
- Virology
- Vaccinology
Background:
- Immune control of human immunodeficiency virus (HIV) is frequently compromised by viral escape mechanisms targeting host cellular and humoral responses.
- HIV vaccine development faces significant hurdles due to the virus's rapid adaptation to selective pressures and its ability to regain fitness upon transmission.
Purpose of the Study:
- To explore factors contributing to protective immune responses against HIV.
- To gain insights into viral kinetics that influence immune control, viral adaptation, and immune escape.
- To guide the design of broadly applicable HIV vaccine candidates.
Main Methods:
- Review of recent studies on immune responses to HIV.
- Analysis of viral kinetics and adaptation mechanisms.
- Investigation of immune correlates of controlled HIV infection.
Main Results:
- HIV's rapid adaptation and global diversity complicate immune response assessment and vaccine design.
- Recent research has identified potential factors for protective immunity and clarified viral kinetics.
- Understanding these elements is crucial for advancing HIV vaccine development.
Conclusions:
- Effective HIV vaccine design requires addressing viral escape, adaptation, and diversity.
- Further research into immune correlates and viral kinetics is essential.
- This knowledge is pivotal for creating broadly protective HIV vaccines.
More Related Videos
11:19Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses
Published on: May 4, 2015
13:13Single-cell Quantitation of mRNA and Surface Protein Expression in Simian Immunodeficiency Virus-infected CD4+ T Cells Isolated from Rhesus macaques
Published on: September 25, 2018
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Size and Structure of Viral Genomes
Viral Mutations
Retrovirus Life Cycles
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Inhibitors of Virion Maturation and Assembly